Regina E Groves's Net Worth
$1.58 Million
Who is Regina E Groves?
Regina E Groves has an estimated net worth of $1.58 Million. This is based on reported shares across multiple companies, which include AtriCure, Inc., REVA Medical, Inc., and Fulgent Genetics, Inc..
SEC CIK
Regina E Groves's CIK is 0001653877
Past Insider Trading and Trends
2017 was Regina E Groves's most active year for acquiring shares with 9 total transactions. Regina E Groves's most active month to acquire stocks was the month of April. 2021 was Regina E Groves's most active year for disposing of shares, totalling 2 transactions. Regina E Groves's most active month to dispose stocks was the month of August. 2016 saw Regina E Groves paying a total of $27,956.98 for 333,608.5 shares, this is the most they've acquired in one year. In 2021 Regina E Groves cashed out on 7,364 shares for a total of $538,613.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AtriCure, Inc. (ATRC) Snapshot price: $33.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.89% | 7.79K |
—
|
—
| 30.77K |
May 13
| |||
Form 4
| +16.10% | 3.19K |
—
|
—
| 22.98K |
May 25
| |||
Form 4
| +21.96% | 3.56K |
—
|
—
| 19.79K |
May 25
| |||
Form 4
| +0.21% | 34 |
$76.68 | $2,607.12 | 16.23K |
Apr 30
| |||
Form 4
| -16.31% | -3.16K |
$74.73 | -$235,847.88 | 16.19K |
Sep 15
| |||
Form 4
| -17.86% | -4.21K |
$71.95 | -$302,765.60 | 19.35K |
May 26
| |||
Form 4
| +8.02% | 1.75K |
—
|
—
| 23.56K |
May 20
| |||
Form 4
| -22.45% | -6.31K |
$41.83 | -$264,072.79 | 21.81K |
Sep 14
| |||
Form 4
| +9.55% | 2.45K |
—
|
—
| 28.12K |
May 20
| |||
Form 4
| +1.99% | 500 |
$24.86 | $12,430.00 | 25.67K |
Sep 12
| |||
Form 4
| +20.07% | 4.21K |
—
|
—
| 25.17K |
May 22
| |||
Form 4
| +33.60% | 5.27K |
—
|
—
| 20.96K |
May 31
| |||
Form 4
| +49.87% | 5.22K |
—
|
—
| 15.69K |
May 22
| |||
Form 4
| +10.56% | 1K |
$17.43 | $17,430.00 | 10.47K |
Mar 1
| |||
Form 4
|
∞
| 9.47K |
—
|
—
| 9.47K |
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REVA Medical, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.16% | 9.82K |
$1.53 | $15,018.02 | 245.92K |
Jun 29
| |||
Form 4
| +93.36% | 114K |
—
|
—
| 236.11K |
May 16
| |||
Form 4
| +0.65% | 794.2 |
$6.37 | $5,058.69 | 122.11K |
Aug 23 - Aug 29
| |||
Form 4
| +0.59% | 705.8 |
$5.74 | $4,049.61 | 121.31K |
Aug 17 - Aug 21
| |||
Form 4
| +32.02% | 29.25K |
—
|
—
| 120.61K |
May 19
| |||
Form 4
| +2,431.76% | 87.75K |
—
|
—
| 91.36K |
Mar 20
| |||
Form 4
| +290.11% | 2.68K |
$7.45 | $20,000.13 | 3.61K |
Jul 15
| |||
Form 4
|
∞
| 925 |
$8.60 | $7,956.85 | 925 |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulgent Genetics, Inc. (FLGT) Snapshot price: $25.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 4K |
—
|
—
| 8K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 4K |
—
|
—
| 4K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||